Molecular basis and therapeutic implications of CD40/CD40L immune checkpoint
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference225 articles.
1. Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin’s lymphoma;Advani;Journal of Clinical Oncology,2009
2. The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells;Ahonen;Nature Immunology,2002
3. Safety, pharmacokinetics and pharmacodynamics of single rising doses of BI 655064, an antagonistic anti-CD40 antibody in healthy subjects: a potential novel treatment for autoimmune diseases;Albach;European Journal of Clinical Pharmacology,2018
4. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40;Alderson;The Journal of Experimental Medicine,1993
5. Interaction of CD154 with different receptors and its role in bidirectional signals;Alturaihi;European Journal of Immunology,2015
Cited by 121 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The construction and experimental verification of a 6-LncRNA model based on Lactic acid metabolism in the tumor microenvironment of Wilms tumor;Gene;2025-01
2. Structural characterization and immune modulation activities of Chinese Angelica polysaccharide (CAP) and selenizing CAP (sCAP) on dendritic cells;International Journal of Biological Macromolecules;2024-10
3. Circulating inflammatory proteins and abdominal aortic aneurysm: A two-sample Mendelian randomization and colocalization analyses;Cytokine;2024-10
4. Specific plasma biomarker signatures associated with patients undergoing surgery for back pain;The Spine Journal;2024-09
5. Dexmedetomidine induces IL-10 secretion by B lymphocytes in the peripheral blood of patients with hepatocellular carcinoma;Immunobiology;2024-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3